StockpollyBeta
Get App
Delisting riskPopularity #4,664
CDIO · NASDAQ · Biotechnology

Cardio Diagnostics (CDIO)

Develops genetic-epigenetic blood tests and clinical intelligence for coronary heart disease.

$1.89
vs last close−0.03 (−1.56%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
124112222122
Research & development000000000000
124112222121
Selling & marketing000000000000
General & administrative114111221111
Other expenses000000000000
Operating income−1−2−4−1−1−2−2−2−2−1−2−1
000000000000
Interest income000000000000
Interest expense100000000000
Other non-operating income000000000000
Income before tax−2−1−4−1−1−2−2−2−2−1−2−2
Net income from continuing operations−2−1−4−1−1−2−2−2−2−1−2−2
Net income−2−1−4−1−1−2−2−2−2−1−2−2
EPS, basic−$0.16−$0.07−$5.93−$1.71−$1.73−$0.06−$0.97−$0.97−$0.98−$0.80−$0.63−$0.51
EPS, diluted−$0.16−$0.07−$5.93−$1.80−$0.06−$0.06−$0.97−$0.97−$0.98−$0.80−$0.63−$0.51
Weighted average shares, basic122111146222233
Weighted average shares, diluted12211232446222233
EBITDA−1−1−4−1−1−1−2−2−2−1−2−1
Depreciation & amortization000000000000
EBIT−1−1−4−1−1−2−2−2−2−1−2−1